Allgens Medical Technology CO., LTD.
Simbolo: 688613.SS
SHH
12.14
CNYPrezzo di mercato oggi
36.3470
Rapporto P/E
4.3143
Rapporto PEG
1.65B
Capitalizzazione MRK
- 0.01%
Rendimento DIV
Allgens Medical Technology CO., LTD. (688613-SS) Bilanci finanziari
Stato patrimoniale
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 4310.19 | 1063.4 | 1076 | 1065.2 | |||||||
balance-sheet.row.short-term-investments | 3600.19 | 902.2 | 816.1 | 653.9 | |||||||
balance-sheet.row.net-receivables | 274.38 | 73.4 | 44.2 | 32.6 | |||||||
balance-sheet.row.inventory | 124.71 | 32.7 | 18.3 | 19 | |||||||
balance-sheet.row.other-current-assets | 46.02 | 31.3 | 3.9 | 4.1 | |||||||
balance-sheet.row.total-current-assets | 4755.3 | 1200.7 | 1142.3 | 1120.9 | |||||||
balance-sheet.row.property-plant-equipment-net | 773.32 | 186.6 | 188.8 | 195.5 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 88.9 | 22.1 | 23.4 | 24.6 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 88.9 | 22.1 | 23.4 | 24.6 | |||||||
balance-sheet.row.long-term-investments | 1462.44 | 1254.8 | 58.6 | 65.8 | |||||||
balance-sheet.row.tax-assets | 80.65 | 21.7 | 18.6 | 14.2 | |||||||
balance-sheet.row.other-non-current-assets | -1113.46 | -1159.7 | 27.5 | 5 | |||||||
balance-sheet.row.total-non-current-assets | 1291.84 | 325.5 | 316.9 | 305.2 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 6047.15 | 1526.3 | 1459.2 | 1426.1 | |||||||
balance-sheet.row.account-payables | 43.74 | 10.4 | 7.4 | 3.3 | |||||||
balance-sheet.row.short-term-debt | 18.63 | 5.1 | 15.7 | 19.1 | |||||||
balance-sheet.row.tax-payables | 5.45 | 1.9 | 6.5 | 2.8 | |||||||
balance-sheet.row.long-term-debt-total | 187.91 | 48.3 | 45.9 | 61.5 | |||||||
Deferred Revenue Non Current | 114.43 | 22.2 | 34.9 | 36.2 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10.96 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 15.26 | 0.3 | 21.4 | 0.1 | |||||||
balance-sheet.row.total-non-current-liabilities | 316.11 | 71.8 | 85 | 100.3 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 8.61 | 3 | 5 | 5 | |||||||
balance-sheet.row.total-liab | 469.36 | 122.6 | 133.5 | 155.5 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 533.33 | 133.3 | 133.3 | 133.3 | |||||||
balance-sheet.row.retained-earnings | 1112.54 | 276 | 239.2 | 190.8 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 3367.01 | 1366.1 | 55 | 44.8 | |||||||
balance-sheet.row.other-total-stockholders-equity | 481.99 | -393.3 | 875.3 | 875.3 | |||||||
balance-sheet.row.total-stockholders-equity | 5494.88 | 1382.1 | 1302.9 | 1244.3 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6047.15 | 1526.3 | 1459.2 | 1426.1 | |||||||
balance-sheet.row.minority-interest | 82.91 | 21.6 | 22.8 | 26.3 | |||||||
balance-sheet.row.total-equity | 5577.79 | 1403.6 | 1325.7 | 1270.6 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 6047.15 | - | - | - | |||||||
Total Investments | 4909.87 | 2157 | 816.1 | 653.9 | |||||||
balance-sheet.row.total-debt | 209.36 | 53.4 | 61.6 | 80.6 | |||||||
balance-sheet.row.net-debt | -500.64 | -107.8 | -198.3 | -330.7 |
Rendiconto finanziario
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 42.33 | 91.7 | 118.1 | 87.1 | ||||||
cash-flows.row.depreciation-and-amortization | 12.88 | 18 | 13.2 | 10.9 | ||||||
cash-flows.row.deferred-income-tax | -0.16 | -2.8 | -1.7 | -6.1 | ||||||
cash-flows.row.stock-based-compensation | 51.7 | 2.8 | 1.7 | 6.1 | ||||||
cash-flows.row.change-in-working-capital | -43.1 | -2.5 | 6.9 | -11.8 | ||||||
cash-flows.row.account-receivables | -30.39 | -12.2 | -9.5 | -9.2 | ||||||
cash-flows.row.inventory | -12.71 | 0.7 | 1.8 | -14.6 | ||||||
cash-flows.row.account-payables | 0 | 11.8 | 16.2 | 18.1 | ||||||
cash-flows.row.other-working-capital | 0 | -2.8 | -1.7 | -6.1 | ||||||
cash-flows.row.other-non-cash-items | -9.16 | -5.2 | -8.3 | -1.3 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 37.32 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | -11.28 | -45.4 | -61.2 | -56.4 | ||||||
cash-flows.row.acquisitions-net | -30.31 | 0 | 168.3 | 478.2 | ||||||
cash-flows.row.purchases-of-investments | -81.62 | -168 | -204 | -478.2 | ||||||
cash-flows.row.sales-maturities-of-investments | 57.07 | 16 | 35.7 | 14.2 | ||||||
cash-flows.row.other-investing-activites | 42.03 | 0 | -168.3 | -101.1 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | -35.44 | -197.4 | -229.5 | -143.3 | ||||||
cash-flows.row.debt-repayment | -28.05 | -8.6 | -34.6 | -2.6 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | -7.7 | 0 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 7.7 | 0 | ||||||
cash-flows.row.dividends-paid | -16.85 | -40.1 | -1.2 | -1.4 | ||||||
cash-flows.row.other-financing-activites | 1.45 | -7.1 | 526 | 8.2 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -28.01 | -55.8 | 490.2 | 4.2 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.19 | -0.3 | 0 | -0.1 | ||||||
cash-flows.row.net-change-in-cash | -26.32 | -151.4 | 390.5 | -54.3 | ||||||
cash-flows.row.cash-at-end-of-period | 710 | 259.9 | 411.3 | 20.8 | ||||||
cash-flows.row.cash-at-beginning-of-period | 736.31 | 411.3 | 20.8 | 75.1 | ||||||
cash-flows.row.operating-cash-flow | 37.32 | 102.1 | 129.8 | 84.9 | ||||||
cash-flows.row.capital-expenditure | -11.28 | -45.4 | -61.2 | -56.4 | ||||||
cash-flows.row.free-cash-flow | 26.04 | 56.6 | 68.5 | 28.5 |
Riga del conto economico
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 225.17 | 226.5 | 245.3 | 236.1 | |||||||
income-statement-row.row.cost-of-revenue | 39.45 | 39.2 | 40.8 | 34.6 | |||||||
income-statement-row.row.gross-profit | 185.72 | 187.2 | 204.5 | 201.5 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 47.08 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 59.97 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 36.95 | - | - | - | |||||||
income-statement-row.row.other-expenses | -48.4 | -177.4 | 23.8 | 20.3 | |||||||
income-statement-row.row.operating-expenses | 170.9 | 177.4 | 121.3 | 80.7 | |||||||
income-statement-row.row.cost-and-expenses | 202.08 | 177.4 | 162 | 115.3 | |||||||
income-statement-row.row.interest-income | 0.74 | 3.3 | 5.6 | 4.3 | |||||||
income-statement-row.row.interest-expense | 2.5 | 3.1 | 1.9 | 3.4 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 36.95 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 3.74 | 0.1 | -0.1 | -2.9 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | -48.4 | -177.4 | 23.8 | 20.3 | |||||||
income-statement-row.row.total-operating-expenses | 3.74 | 0.1 | -0.1 | -2.9 | |||||||
income-statement-row.row.interest-expense | 2.5 | 3.1 | 1.9 | 3.4 | |||||||
income-statement-row.row.depreciation-and-amortization | -0.88 | 18 | 10.5 | 0.9 | |||||||
income-statement-row.row.ebitda-caps | 27.27 | - | - | - | |||||||
income-statement-row.row.operating-income | 31.84 | 49 | 96.3 | 134.9 | |||||||
income-statement-row.row.income-before-tax | 35.58 | 49.1 | 96.2 | 132 | |||||||
income-statement-row.row.income-tax-expense | -6.51 | -3.9 | 4.5 | 14 | |||||||
income-statement-row.row.net-income | 44.53 | 54.2 | 95.2 | 120.8 |
Domande frequenti
Che cos'è Allgens Medical Technology CO., LTD. (688613.SS) totale attivo?
Allgens Medical Technology CO., LTD. (688613.SS) il totale delle attività è 1526256853.000.
Qual è il fatturato annuo dell'impresa?
Il fatturato annuo è 89380712.000.
Qual è il margine di profitto dell'azienda?
Il margine di profitto dell'azienda è 0.825.
Qual è il flusso di cassa libero dell'azienda?
Il flusso di cassa libero è 0.195.
Qual è il margine di profitto netto dell'impresa?
Il margine di profitto netto è 0.198.
Qual è il fatturato totale dell'azienda?
Le entrate totali sono 0.141.
Che cos'è il Allgens Medical Technology CO., LTD. (688613.SS) utile netto (reddito netto)?
L'utile netto (reddito netto) è 54231840.000.
Qual è il debito totale dell'azienda?
Il debito totale è 53416683.000.
Qual è il numero di spese operative?
Le spese operative sono 177437900.000.
Qual è la cifra della liquidità aziendale?
La liquidità aziendale è 178413682.000.